Cargando…
Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever
Yellow fever is an infectious disease, endemic in South America and Africa. This is a potentially serious illness, with lethality between 5 and 40% of cases. The most effective preventive vaccine is constituted by the attenuated virus strain 17D, developed in 1937. It is considered safe and effectiv...
Autores principales: | Oliveira, Ana Cristina Vanderley, Maria Henrique da Mota, Licia, dos Santos-Neto, Leopoldo Luiz, De Carvalho, Jozélio Freire, Caldas, Iramaya Rodrigues, Martins Filho, Olindo Assis, Tauil, Pedro Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227414/ https://www.ncbi.nlm.nih.gov/pubmed/25405025 http://dx.doi.org/10.1155/2014/473170 |
Ejemplares similares
-
Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis
por: Ferreira, Clarissa de Castro, et al.
Publicado: (2019) -
Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals
por: Bonin, Carla Rezende Barbosa, et al.
Publicado: (2020) -
17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children
por: Campi-Azevedo, Ana Carolina, et al.
Publicado: (2012) -
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children
por: Campi-Azevedo, Ana Carolina, et al.
Publicado: (2019) -
Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation
por: Possas, Cristina, et al.
Publicado: (2018)